Back

PVI, PeerView Institute for Medical Education

  • Antibodies, Bispecific
  • Carcinoma, Non-Small-Cell Lung
  • Small Cell Lung Carcinoma

Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes

Building a Better Backbone for Lung Cancer Treatment With PD-(L)1 x VEGF Bispecific Antibodies

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABIM — Medical KnowledgeUp to 1 pointABIM — Patient SafetyUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Commercial Support
  • Released
    Sep 13, 2026
  • Last day to claim credit
    Oct 13, 2027 1 year left